Rationale and Design for the LUME-Colon 1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Nintedanib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Colorectal Cancer Refractory to Standard Treatment

Publication | Closed Access

DOI

Citations

References

2015

Year

Eric Van Cutsem, Takayuki Yoshino, Julia Hocke, Zohra Oum'Hamed, Matus Studeny, Josep Tabernero

Clinical Colorectal Cancer

MedicineCancer ManagementStandard TreatmentColorectal CancerSurgeryLume-colon 1OncologyRadiation Oncology